Association between p22PHOX gene C242T polymorphism and hypertension in end-stage kidney disease patients

[1]  N. Zhang,et al.  Gender-specific association between Apelin/APJ gene polymorphisms and hypertension risk in Southeast China. , 2018, Gene.

[2]  Jia Su,et al.  Gender-Specific Association of ATP2B1 Variants with Susceptibility to Essential Hypertension in the Han Chinese Population , 2016, BioMed research international.

[3]  Sanjay Tyagi,et al.  CYBA (p22phox) variants associate with blood pressure and oxidative stress markers in hypertension: a replication study in populations of diverse altitudes , 2015, Hypertension Research.

[4]  D. Afroze,et al.  C242T polymorphism of the NADPH oxidase p22PHOX gene and its association with endothelial dysfunction in asymptomatic individuals with essential systemic hypertension. , 2014, Molecular medicine reports.

[5]  D. Petrovič.  Association of the −262C/T polymorphism in the catalase gene promoter and the C242T polymorphism of the NADPH oxidase P22phox gene with essential arterial hypertension in patients with diabetes mellitus type 2 , 2014, Clinical and experimental hypertension.

[6]  Bao-yun Liang,et al.  The A930G Polymorphism of P22phox (CYBA) Gene but Not C242T Variation Is Associated with Hypertension: A Meta-Analysis , 2013, PloS one.

[7]  B. Burguera,et al.  NADPH oxidase p22phox polymorphisms and oxidative stress in patients with obstructive sleep apnoea. , 2011, Respiratory medicine.

[8]  G. Zalba,et al.  CYBA gene variants as biomarkers for coronary artery disease. , 2010, Drug news & perspectives.

[9]  R. Touyz,et al.  Molecular mechanisms of hypertension: role of Nox family NADPH oxidases. , 2009, Current opinion in nephrology and hypertension.

[10]  A. Castelnuovo,et al.  The C242T polymorphism of the p22phox component of NAD (P)H oxidase and vascular risk , 2008, Thrombosis and Haemostasis.

[11]  I. Hoffmann,et al.  NAD(P)H oxidase p22phox gene C242T polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics , 2006, Journal of Human Hypertension.

[12]  J. Díez,et al.  The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension , 2006, Journal of hypertension.

[13]  G. Zalba,et al.  NADPH oxidase-mediated oxidative stress: genetic studies of the p22(phox) gene in hypertension. , 2005, Antioxidants & redox signaling.

[14]  R. de Caterina,et al.  Oxidative stress and cardiovascular risk: the role of vascular NAD(P)H oxidase and its genetic variants , 2005, European journal of clinical investigation.

[15]  I. Nagaoka,et al.  Functional effects of NAD(P)H oxidase p22(phox) C242T mutation in human leukocytes and association with thrombotic cerebral infarction. , 2004, Atherosclerosis.

[16]  K. Griendling,et al.  Reactive oxygen species in the vasculature: molecular and cellular mechanisms. , 2003, Hypertension.

[17]  R. Clempus,et al.  Vascular NAD(P)H oxidases: specific features, expression, and regulation. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[18]  A. Zeiher,et al.  NADH/NADPH oxidase p22 phox gene polymorphism is associated with improved coronary endothelial vasodilator function. , 2001, European heart journal.

[19]  K. Channon,et al.  Functional Effect of the C242T Polymorphism in the NAD(P)H Oxidase p22phox Gene on Vascular Superoxide Production in Atherosclerosis , 2000, Circulation.

[20]  K. Channon,et al.  Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. , 2000, Circulation research.

[21]  D. Sorescu,et al.  NAD(P)H oxidase: role in cardiovascular biology and disease. , 2000, Circulation research.

[22]  A. Gotto,et al.  A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. , 2000, Circulation research.

[23]  K. Channon,et al.  Association of superoxide production by NAD(P)H oxidase with systaemic endothelial dysfunction in human blood vessels: relationship to clinical risk factors , 2000 .

[24]  S. Orkin,et al.  Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. , 1990, The Journal of clinical investigation.